Logo image of ARBS.MI

ARTERRA BIOSCIENCE SPA (ARBS.MI) Stock Price, Forecast & Analysis

Europe - Euronext Milan - BIT:ARBS - IT0005386369 - Common Stock

3.08 EUR
-0.04 (-1.28%)
Last: 1/13/2026, 7:00:00 PM

ARBS.MI Key Statistics, Chart & Performance

Key Statistics
Market Cap20.51M
Revenue(TTM)4.49M
Net Income(TTM)1.90M
Shares6.66M
Float2.64M
52 Week HighN/A
52 Week LowN/A
Yearly Dividend0.11
Dividend Yield4.19%
EPS(TTM)0.3
PE10.27
Fwd PEN/A
Earnings (Next)N/A
IPO2019-10-28
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
ARBS.MI short term performance overview.The bars show the price performance of ARBS.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60

ARBS.MI long term performance overview.The bars show the price performance of ARBS.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of ARBS.MI is 3.08 EUR. In the past month the price increased by 22.22%.

ARTERRA BIOSCIENCE SPA / ARBS Daily stock chart

ARBS.MI Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to ARBS.MI.


Chartmill TA Rating
Chartmill Setup Rating

ARBS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ARBS.MI. While ARBS.MI seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ARBS.MI Financial Highlights

Over the last trailing twelve months ARBS.MI reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 37.48% compared to the year before.


Industry RankSector Rank
PM (TTM) 42.38%
ROA 13.59%
ROE 16.33%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%109.79%
Sales Q2Q%14.28%
EPS 1Y (TTM)37.48%
Revenue 1Y (TTM)13.44%

ARBS.MI Forecast & Estimates

7 analysts have analysed ARBS.MI and the average price target is 3.88 EUR. This implies a price increase of 25.84% is expected in the next year compared to the current price of 3.08.


Analysts
Analysts82.86
Price Target3.88 (25.97%)
EPS Next YN/A
Revenue Next YearN/A

ARBS.MI Ownership

Ownership
Inst Owners0.16%
Ins Owners46.87%
Short Float %N/A
Short RatioN/A

About ARBS.MI

Company Profile

ARBS logo image Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.

Company Info

ARTERRA BIOSCIENCE SPA

via Benedetto Brin, 69

Naples NAPOLI IT

Employees: 30

ARBS Company Website

ARBS Investor Relations

Phone: 390816584411

ARTERRA BIOSCIENCE SPA / ARBS.MI FAQ

Can you describe the business of ARTERRA BIOSCIENCE SPA?

Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.


What is the stock price of ARTERRA BIOSCIENCE SPA today?

The current stock price of ARBS.MI is 3.08 EUR. The price decreased by -1.28% in the last trading session.


What is the dividend status of ARTERRA BIOSCIENCE SPA?

ARTERRA BIOSCIENCE SPA (ARBS.MI) has a dividend yield of 4.19%. The yearly dividend amount is currently 0.11.


What is the ChartMill rating of ARTERRA BIOSCIENCE SPA stock?

ARBS.MI has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Where is ARTERRA BIOSCIENCE SPA (ARBS.MI) stock traded?

ARBS.MI stock is listed on the Euronext Milan exchange.


What is the ownership structure of ARTERRA BIOSCIENCE SPA (ARBS.MI)?

You can find the ownership structure of ARTERRA BIOSCIENCE SPA (ARBS.MI) on the Ownership tab.